help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohashi, K.
Right arrow Articles by Tanizawa, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohashi, K.
Right arrow Articles by Tanizawa, O.

Journal of Clinical Endocrinology & Metabolism, Vol 74, 130-134, Copyright © 1992 by Endocrine Society

ARTICLES

Tumor necrosis factor-alpha inhibits human chorionic gonadotropin secretion

K Ohashi, F Saji, M Kato, A Wakimoto and O Tanizawa
Department of Obstetrics and Gynecology, Osaka University Medical School, Japan.

The placenta is a major source of tumor necrosis factor-alpha (TNF alpha) and is rich in TNF alpha receptors. TNF alpha inhibited hCG secretion by normal chorionic villi at 6 weeks gestation, but chorionic villi contain the heterogenous cell population. To investigate the direct effects of TNF alpha on trophoblasts, the NUC1 choriocarcinoma cell line was used as an in vitro placental cell model. TNF alpha also inhibited hCG secretion by NUC1 cells at concentrations from 1-100 U/mL. TNF alpha at concentrations of 1, 10, and 100 U/mL significantly decreased hCG secretion for 24 h to 88%, 81%, and 71% of the control level, respectively. The expression of hCG beta mRNA was also decreased to 23% of the control level after 24 h of TNF alpha treatment (100 U/mL). Inhibition occurred after 12 h of TNF alpha treatment (100 U/mL). Two measurements, trypan blue dye exclusion and 3-(4,5- dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide reduction, revealed that these inhibitory effects were not due to the cytotoxic activity of TNF alpha on NUC1. In conclusion, TNF alpha reduces hCG secretion in vitro.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
R. M. Gill and J. S. Hunt
Soluble Receptor (DcR3) and Cellular Inhibitor of Apoptosis-2 (cIAP-2) Protect Human Cytotrophoblast Cells Against LIGHT-Mediated Apoptosis
Am. J. Pathol., July 1, 2004; 165(1): 309 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
A. Meisser, D. Chardonnens, A. Campana, and P. Bischof
Effects of tumour necrosis factor-{alpha}, interleukin-1 {alpha}, macrophage colony stimulating factor and transforming growth factor ß on trophoblastic matrix metalloproteinases
Mol. Hum. Reprod., March 1, 1999; 5(3): 252 - 260.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
D. T. Vandermolen, S. W. Kauma, and T. T. Turner
Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} Stimulate Granulocyte Colony-Stimulating Factor Production by Placental Villous Core Mesenchymal Cells
Reproductive Sciences, July 1, 1996; 3(4): 172 - 178.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society